UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in The Cigna Group (NYSE:CI - Free Report) by 15.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,495,592 shares of the health services provider's stock after purchasing an additional 326,633 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.90% of The Cigna Group worth $689,133,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also bought and sold shares of CI. TCTC Holdings LLC acquired a new position in The Cigna Group in the 4th quarter worth about $25,000. Collier Financial bought a new stake in shares of The Cigna Group in the 4th quarter valued at about $32,000. Compagnie Lombard Odier SCmA bought a new stake in shares of The Cigna Group in the 4th quarter valued at about $37,000. Transce3nd LLC bought a new stake in shares of The Cigna Group in the 4th quarter valued at about $38,000. Finally, Heck Capital Advisors LLC bought a new stake in shares of The Cigna Group in the 4th quarter valued at about $53,000. Institutional investors and hedge funds own 86.99% of the company's stock.
Insiders Place Their Bets
In other The Cigna Group news, insider Nicole S. Jones sold 4,904 shares of the stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $308.12, for a total value of $1,511,020.48. Following the transaction, the insider now owns 29,421 shares in the company, valued at approximately $9,065,198.52. This represents a 14.29% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO David Cordani sold 26,527 shares of the firm's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $308.12, for a total value of $8,173,499.24. Following the completion of the transaction, the chief executive officer now owns 127,767 shares in the company, valued at $39,367,568.04. This represents a 17.19% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 43,751 shares of company stock worth $13,603,991. Corporate insiders own 0.70% of the company's stock.
The Cigna Group Trading Up 1.2%
Shares of The Cigna Group stock traded up $3.68 on Friday, hitting $316.36. 1,667,838 shares of the company's stock traded hands, compared to its average volume of 1,714,787. The company has a fifty day moving average of $325.35 and a two-hundred day moving average of $310.06. The company has a market capitalization of $84.51 billion, a price-to-earnings ratio of 25.85, a price-to-earnings-growth ratio of 0.98 and a beta of 0.47. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72. The Cigna Group has a one year low of $262.03 and a one year high of $370.83.
The Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings results on Friday, May 2nd. The health services provider reported $6.74 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.35 by $0.39. The business had revenue of $65.45 billion for the quarter, compared to analyst estimates of $60.39 billion. The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. The company's quarterly revenue was up 14.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.47 earnings per share. As a group, sell-side analysts expect that The Cigna Group will post 29.77 earnings per share for the current year.
The Cigna Group Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 18th. Shareholders of record on Tuesday, June 3rd will be issued a $1.51 dividend. The ex-dividend date of this dividend is Tuesday, June 3rd. This represents a $6.04 annualized dividend and a yield of 1.91%. The Cigna Group's payout ratio is currently 33.44%.
Analyst Upgrades and Downgrades
A number of equities research analysts have commented on CI shares. Truist Financial upped their price target on The Cigna Group from $385.00 to $405.00 and gave the company a "buy" rating in a research report on Monday, May 12th. Barclays upped their price target on The Cigna Group from $339.00 to $382.00 and gave the company an "overweight" rating in a research report on Monday, May 5th. Robert W. Baird reduced their price target on The Cigna Group from $388.00 to $362.00 and set an "outperform" rating on the stock in a research report on Tuesday, April 15th. Mizuho upped their price target on The Cigna Group from $360.00 to $384.00 and gave the company an "outperform" rating in a research report on Wednesday, April 9th. Finally, Raymond James reiterated a "strong-buy" rating and issued a $360.00 price target (down previously from $415.00) on shares of The Cigna Group in a research report on Friday, January 31st. Two investment analysts have rated the stock with a hold rating, sixteen have issued a buy rating and three have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Buy" and an average price target of $379.33.
View Our Latest Report on CI
About The Cigna Group
(
Free Report)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
See Also

Before you consider The Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Cigna Group wasn't on the list.
While The Cigna Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.